Lutein |
Antiproliferative |
Lutein induced a decrease in the proliferation of PC-3 cells (in vitro), modulating the expression of growth genes associated with prostate cancer cells. |
[98] |
Antioxidant activity |
Healthy subjects supplemented with 12 mg/d of lutein for 12 weeks showed improved visual function, particularly in contrast sensitivity. |
[99] |
Neuroprotective |
Rats supplemented with lutein (30, 15, and 7.5 mg/kg) significantly elevated the activities of superoxide dismutase, glutathione peroxidase, and catalase in brain and decreased the neurological deficit scores. |
[100] |
Neuroprotective |
Rats supplemented with lutein (50–100 mg/kg) for 14 days showed a fat loss, reduced neurobehavioral alterations, and reduced oxidative stress. |
[101] |
Antidiabetic and obesity control |
Rats supplemented with lutein significantly improved body weight, hepatic levels of lipid accumulation, and insulin sensitivity. |
[102] |
β-carotene |
Apoptotic |
β-carotene (1 μM) induced apoptosis in MCF cells by caspase-3 activity and inhibited the expression of the anti-apoptotic proteins, Bcl-2 and PARP. |
[103] |
Antioxidant activity |
Patients supplemented with 60 mg/d of β-carotene for 3 weeks showed a reduction in LDL susceptibility to oxidation. |
[104] |
Antioxidant activity |
The content of β-carotene in plasma was significantly and positively correlated with telomerase activity of Alzheimer disease patients, independent of gender. |
[105] |